regeneron glp-1 GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates Regeneron posts update on its

To enhance the pharmacological properties of the ruthenium catalyst, provide cancer selectivity for the treatment, and enable the treatment of challenging hypoxic tumors, the metal complexes were covalently conjugated to the side chains of polymers with a carbon fluorinated moiety that could co-deliver oxygen to the tumor

The protein content was measured using the Pierce BCA Protein Assay Kit

Here is the caveat that most consumer articles omit: the tripeptide in that landmark study was AHK-Cu L-alanyl-L-histidyl-L-lysine copper, sometimes labeled copper tripeptide-3 not GHK-Cu

Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors